首页> 外文期刊>International journal of oral and maxillofacial surgery >A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model.
【24h】

A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model.

机译:一项随机,双盲,安慰剂对照的研究,使用牙科撞击痛模型比较了扑热息痛,serratiopeptidase,布洛芬和倍他米松的疗效和安全性。

获取原文
获取原文并翻译 | 示例
           

摘要

Assessment of postoperative sequelae following the removal of an impacted third molar has been used in clinical pharmacology to evaluate the relative efficacy of various analgesic, anti-inflammatory drugs. This study included 150 patients with impacted lower third molars. They were randomly sorted to receive ibuprofen, paracetamol, betamethasone, serratiopeptidase or placebo. Evaluation of efficacy was made using tape measurement (for swelling), visual analogue scale (for pain evaluation), mouth opening ability and oral temperature. The effect of treatment on hematological parameters, bleeding, wound healing and requirement for rescue medication was also studied. Peak pain scores were observed approximately 5-6 hours after the operation. Betamethasone showed significant analgesic activity from day 1. Ibuprofen and betamethasone were significantly more effective than placebo in reducing swelling. Trismus was least with betamethasone. A significant rise in temperature on the operated side occurred only on day 1 in all the groups. Serratiopeptidase did not showed significant analgesic and anti-inflammatory action. Mild-to-moderate adverse effects were reported.
机译:在临床药理学中已经评估了去除受影响的第三磨牙后的术后后遗症,以评估各种止痛,抗炎药的相对疗效。这项研究包括150名患上第三磨牙的患者。他们被随机分选以接受布洛芬,扑热息痛,倍他米松,serratiopeptidase或安慰剂。使用卷尺(用于肿胀),视觉模拟量表(用于疼痛评估),张口能力和口腔温度进行疗效评估。还研究了治疗对血液学参数,出血,伤口愈合和急救药物需求的影响。术后约5-6小时观察到疼痛峰值。从第1天开始,倍他米松显示出明显的镇痛活性。布洛芬和倍他米松在减轻肿胀方面比安慰剂有效得多。 Trismus与倍他米松最少。在所有组中,仅在第1天,手术侧的温度才出现明显升高。 Serratiopeptidase没有显示出明显的镇痛和抗炎作用。据报道轻至中度的不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号